NCT02419755: Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies |
|
|
| Terminated | 2 | 12 | US | Bortezomib, Velcade, PS-341, MLN341, LDP-341, Vorinostat, Zolinza, Suberoylanilide Hydroxamic Acid, SAHA, Mitoxantrone, Novantrone, Cytarabine, Ara-C, Cytosar, Methotrexate, ITMHA, Intrathecal Triples, Hydrocortisone, Peg-L-Asparaginase, Pegaspargase, Oncaspar, Erwinia L-Asparaginase, Erwinase, Dexamethasone, Decadron, Mercaptopurine, 6-MP, Purinethol, Doxorubicin, Adriamycin® | St. Jude Children's Research Hospital | Mixed Lineage Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoid Leukemia | 12/16 | 12/16 | | |
NCT02433483: Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients |
|
|
| Terminated | 2 | 4 | US | Cytarabine, Cytosine arabinoside, Ara-C, Cytosar®, Intrathecal Triples, ITMHA, Methotrexate/hydrocortisone/cytarabine, HPC-A, Donor infusion, Hematopoietic Progenitor Cell, Apheresis | St. Jude Children's Research Hospital, Cookies for Kids' Cancer | Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | 05/17 | 05/17 | | |
NCT00005802: Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia |
|
|
| Completed | 1/2 | | US | aldesleukin, filgrastim, therapeutic allogeneic lymphocytes, cytarabine, etoposide, fludarabine phosphate, methotrexate, mitoxantrone hydrochloride, therapeutic hydrocortisone, radiation therapy | Fred Hutchinson Cancer Center, National Cancer Institute (NCI) | Leukemia | 03/05 | 03/05 | | |
